Home > > > Report Detail

Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Publisher Name :
Date: 21-Sep-2020
No. of pages: 131
Inquire Before Buying

The global hemophilia market is anticipated to reach US$13.86 billion in 2024, growing at a CAGR of 5.61% during the period spanning 2020-2024. The growth in the market has been driven by factors like increasing healthcare expenditure and surging identified hemophilia patient volume. The market is expected to face certain challenges such as high cost of treatment and reluctance to switch to newer therapies. To overcome these challenges, the market would witness some key trends like development of novel hemophilia treatments and rising popularity of gene therapy.

The global hemophilia market by treatment regimen can be segmented as follows: prophylaxis and on-demand. In 2019, the higher share was held by prophylaxis segment, followed by on-demand segment. The global hemophilia market by type can be segmented into the following: hemophilia A and hemophilia B, where hemophilia A held a larger share of the market in 2019. The global hemophilia market by therapy can be segmented as follows: replacement therapy and ITI therapy. The dominant share of the market in 2019 was held by replacement therapy segment. The global hemophilia market by region can be segmented into the following regions: North America, Europe and Asia Pacific.

In 2019, the dominant share of the market was held by North America, followed by Europe and Asia Pacific. The factors like rising prevalence of hemophilia, growing knowledge amongst individuals regarding different treatment methods and surging inclination towards prophylaxis treatment contributed towards growth in the North American market.

Scope of the report:


  • The report provides a comprehensive analysis of the global hemophilia market, segmented into hemophilia A and hemophilia B.

  • The major regional markets North America, Europe and Asia Pacific with country analysis of the US have been analyzed.

  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Pfizer Inc., Bayer Group, Sanofi S.A., Takeda Pharmaceutical Company, Novo Nordisk and CSL Limited) are also presented in detail.


Key Target Audience:


  • Hemophilia Drugs Manufacturers

  • API Suppliers

  • End Users (Hospital, Medical centers, Clinical Institutes)

  • Healthcare Consulting Firms

  • Investment Banks

  • Government Bodies & Regulating Authorities

Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Table of Contents

1. Market Overview 
1.1 Hemophilia 
1.2 Types of Hemophilia 
1.3 Signs & Symptoms 
1.4 Diagnosis of Hemophilia
1.5 Treatment of Hemophilia

2. Impact of COVID-19
2.1 Impact on Global Economy
2.2 Global Prevalence of COVID-19
2.3 Impact on Healthcare Spending

3. Global Market Analysis
3.1 Global Hemophilia Market by Value 
3.2 Global Hemophilia Market Forecast by Value 
3.3 Global Hemophilia Market by Treatment Regimen
3.4 Global Hemophilia Market by Type
3.4.1 Global Hemophilia A Market Forecast by Value 
3.4.2 Global Hemophilia A Market by Severity
3.4.3 Global Hemophilia A Market by Treatment Type
3.4.4 Global Hemophilia A Market by Treatment Regimen
3.4.5 Global Hemophilia A Market Value by Treatment Regimen
3.4.6 Global Hemophilia B Market Forecast by Value 
3.4.7 Global Hemophilia B Market by Severity 
3.4.8 Global Hemophilia B Market by Treatment Type
3.4.9 Global Hemophilia B Market by Treatment Regimen 
3.4.10 Global Hemophilia B Market Value by Treatment Regimen 
3.5 Global Hemophilia Market by Therapy
3.5.1 Global Hemophilia Replacement Therapy Market Forecast by Value
3.5.2 Global Hemophilia ITI Therapy Market Forecast by Value
3.6 Global Hemophilia Market by Region

4. Regional Market Analysis
4.1 North America
4.1.1 North America Hemophilia Market by Value 
4.1.2 North America Hemophilia Market Forecast by Value 
4.1.3 The US Hemophilia Market by Value 
4.1.4 The US Hemophilia Market Forecast by Value 
4.1.5 The US Hemophilia Market by Type 
4.1.6 The US Hemophilia A Market Forecast by Value
4.1.7 The US Hemophilia A Treated Patient Volume Forecast
4.1.8 The US Hemophilia A Severe Patients on Prophylactic Therapy
4.1.9 The US Hemophilia A Severe Patients on On-Demand Therapy
4.1.10 The US Hemophilia A Mild to Moderate Patients on Prophylaxis Therapy
4.1.11 The US Hemophilia A Mild to Moderate Patients on On-Demand Therapy
4.1.12 The US Hemophilia B Market Forecast by Value 
4.1.13 The US Hemophilia B Treated Patients Volume Forecast 
4.1.14 The US Hemophilia B Severe Patients on Prophylaxis Therapy
4.1.15 The US Hemophilia B Severe Patients on On-Demand Therapy
4.1.16 The US Hemophilia B Mild to Moderate Patients on Prophylaxis Therapy
4.1.17 The US Hemophilia B Mild to Moderate Patients on On-Demand Therapy
4.2 Europe 
4.2.1 Europe Hemophilia Market by Value
4.2.2 Europe Hemophilia Market Forecast by Value
4.2.3 Europe Hemophilia Patient Volume Forecast
4.2.4 Europe Hemophilia A Patient Volume Forecast
4.2.5 Europe Hemophilia B Patient Volume Forecast
4.3 Asia Pacific
4.3.1 Asia Pacific Hemophilia Market by Value
4.3.2 Asia Pacific Hemophilia Market Forecast by Value
4.4 ROW
4.4.1 ROW Hemophilia Market by Value 
4.4.2 ROW Hemophilia Market Forecast by Value

5. Market Dynamics
5.1 Growth Drivers 
5.1.1 Increased Focus on Prophylactic Treatment 
5.1.2 Increasing Diagnosis Rate 
5.1.3 Rise in Global Healthcare Expenditure 
5.2 Key Trends & Development
5.2.1 Shifting Focus to Extended Half Life Therapies
5.2.2 Development of Novel Hemophilia Treatments
5.2.3 Popularity of Gene Therapy
5.3 Challenges 
5.3.1 High Cost of Treatment 
5.3.2 Reluctance to Switch to New Therapies

6. Competitive Landscape
6.1 Global Market 
6.1.1 Revenue Comparison – Key Players
6.1.2 Market Capitalization Comparison– Key Players
6.1.3 Research & Development Expenses Comparison – Key Players
6.1.4 Global Hemophilia A Market Share by Company 
6.1.5 Global Hemophilia A Factor VIII Products Market Share by Company 
6.1.6 Global Hemophilia A FVIII Gene Therapy Market Share Forecast 
6.1.7 Global Hemophilia B Market Share by Company
6.1.8 Global Hemophilia B Factor IX Products Market Share Forecast
6.1.9 Global Hemophilia B Factor IX Gene Therapy Market Share Forecast 
6.1.10 Key Players – Major Anti-Hemophilia Products 
6.2 The US Market
6.2.1 The US Hemophilia A Market Share by Company
6.3 Europe Market 
6.3.1 Europe Hemophilia A Market Share by Company

7. Company Profiles
7.1 Pfizer Inc. 
7.1.1 Business Overview 
7.1.2 Financial Overview 
7.1.3 Business Strategies 
7.2 Bayer Group 
7.2.1 Business Overview 
7.2.2 Financial Overview 
7.2.3 Business Strategies 
7.3 Sanofi S.A. 
7.3.1 Business Overview 
7.3.2 Financial Overview 
7.3.3 Business Strategies 
7.4 Takeda Pharmaceutical Company 
7.4.1 Business Overview 
7.4.2 Financial Overview 
7.4.3 Business Strategies 
7.5 Novo Nordisk
7.5.1 Business Overview 
7.5.2 Financial Overview 
7.5.3 Business Strategies 
7.6 CSL Limited 
7.6.1 Business Overview 
7.6.2 Financial Overview 
7.6.3 Business Strategies

List of Tables

Signs & Symptoms of Hemophilia 
Extended Half Life Products (2019)
Development of New Novel Hemophilia Treatments (2019)
Hemophilia Gene Therapy Candidates (2018/2019)
Key Players – Revenue Comparison (2019/2020) 
Key Players – Market Capitalization Comparison (2020)
Key Players - Research & Development Expenses Comparison (2019/2020) 
Key Players – Main Anti-Hemophilia Products

List of Charts

Types of Hemophilia 
Diagnosis of Hemophilia 
Global Coronavirus Prevalence (Jan’20 – Sep’20)
Global Hemophilia Market by Value (2015-2019)
Global Hemophilia Market Forecast by Value (2020-2024)
Global Hemophilia Market by Treatment Regimen (2019) 
Global Hemophilia Market by Type (2019)
Global Hemophilia A Market Forecast by Value (2019-2024)
Global Hemophilia A Market by Severity (2019)
Global Hemophilia A Market by Treatment Type (2019)
Global Hemophilia A Market by Treatment Regimen (2019 & 2024)
Global Hemophilia A Market Value by Treatment Regimen (2019-2024)
Global Hemophilia B Market Forecast by Value (2019-2024)
Global Hemophilia B Market by Severity (2019)
Global Hemophilia B Market by Treatment Type (2019)
Global Hemophilia B Market by Treatment Regimen (2019 & 2024)
Global Hemophilia B Market Value by Treatment Regimen (2019-2024)
Global Hemophilia Market by Therapy (2019)
Global Hemophilia Replacement Therapy Market Forecast by Value (2019-2024)
Global Hemophilia ITI Therapy Market Forecast by Value (2019-2024)
Global Hemophilia Market by Region (2019)
North America Hemophilia Market by Value (2015-2019) 
North America Hemophilia Market Forecast by Value (2020-2024) 
The US Hemophilia Market by Value (2015-2019) 
The US Hemophilia Market Forecast by Value (2020-2024) 
The US Hemophilia Market by Type (2019) 
The US Hemophilia A Market Forecast by Value (2019-2024) 
The US Hemophilia A Treated Patient Volume Forecast (2019-2024)
The US Hemophilia A Severe Patients on Prophylactic Therapy (2019-2024)
The US Hemophilia A Severe Patients on On-Demand Therapy (2019-2024)
The US Hemophilia A Mild to Moderate Patients on Prophylaxis Therapy (2019-2023)
The US Hemophilia A Mild to Moderate Patients on On-Demand Therapy (2019-2024)
The US Hemophilia B Market Forecast by Value (2019-2024) 
The US Hemophilia B Treated Patients Volume Forecast (2019-2024)
The US Hemophilia B Severe Patients on Prophylaxis Therapy (2019-2024) 
The US Hemophilia B Severe Patients on On-Demand Therapy (2019-2024) 
The US Hemophilia B Mild to Moderate Patients on Prophylaxis Therapy (2019-2024) 
The US Hemophilia B Mild to Moderate Patients on On-Demand Therapy (2019-2024) 
Europe Hemophilia Market by Value (2015-2019)
Europe Hemophilia Market Forecast by Value (2020-2024)
Europe Hemophilia Patient Volume Forecast (2019-2024)
Europe Hemophilia A Patient Volume Forecast (2019-2024)
Europe Hemophilia B Patient Volume Forecast (2019-2024)
Asia Pacific Hemophilia Market by Value (2015-2019)
Asia Pacific Hemophilia Market Forecast by Value (2020-2024)
ROW Hemophilia Market by Value (2015-2019)
ROW Hemophilia Market Forecast by Value (2020-2023)
Global Market Share of Hemophilia A and B Patients on Prophylaxis (2019)
Global Identified Hemophilia Patients Volume (2012-2019)
Global Healthcare Expenditure (2014-2018) 
Global Hemophilia A Market Share by Company (2019) 
Global Hemophilia A Factor VIII Products Market Share by Company (2023/2030)
Global Hemophilia A FVIII Gene Therapy Market Share Forecast (2030) 
Global Hemophilia B Market Share by Company (2019)
Global Hemophilia B Factor IX Products Market Share Forecast (2023/2030)
Global Hemophilia B Factor IX Gene Therapy Market Share Forecast (2030)
The US Hemophilia A Market Share by Company (2019) 
Europe Hemophilia B Market Share by Company (2019)
Pfizer Inc. Revenue and Net Income (2015-2019)
Pfizer Inc. Revenue by Segment (2019)
Pfizer Inc. Revenue by Region (2019)
Bayer Group Net Sales and Net Income (2014-2018) 
Bayer Group Net Sales and Net Income (2014-2018) 
Bayer Group Net Sales and Net Income (2014-2018) 
Sanofi S.A. Net Sales and Net Income (2014-2018) 
Sanofi S.A. Net Sales by Segment (2019)
Sanofi S.A. Net Sales by Region (2019)
Takeda Pharmaceutical Company Revenue and Net Income (2016-2020) 
Takeda Pharmaceutical Company Revenue by Segment (2020)
Takeda Pharmaceutical Company Revenue by Region (2020)
Novo Nordisk Net Sales and Net Profit (2014-2018)
Novo Nordisk Net Sales by Segment (2019)
Novo Nordisk Net Sales by Region (2019)
CSL Limited Sales Revenue and Net Profit (2016-2020) 
CSL Limited Sales Revenue by Segment (2020)
CSL Limited Sales Revenue by Region (2020)

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs